Hepatitis C virus infection in dialysis and renal transplantation

Kidney International

Volumn 51, Issue 4, 1997, Pages 981-999

  Pereira, Brian J G ^a,b   Levey, Andrew S ^a  

^a New England Medical Center ^*

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0030971482     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.139     Document Type: Article

References (273)

1. MAHONY JF: Long-term results and complications of renal transplantation: The kidney. Transplant Proc 21:1433-1434, 1989
2. LAQUAGLIA MP, TOLKOFF-RUBIN NE, DIENSTAG JL, ET AL: Impact of hepatitis on renal transplantation. Transplantation 32:504-507, 1981
3. BOYCE NW, HOLDSWORTH SR, HOOKE D, THOMSON NM, ATKINS RC: Non-hepatitis B-related liver disease in a renal transplant population. Am J Kid Dis 11:307-312, 1988
4. WEIR MR, KIRKMAN RL, STROM TB, TILNEY NL: Liver disease in recipients of long-surviving renal allografts. Kidney Int 28:839-844, 1985
5. PARFREY PS, FORBES RDC, HUTCHINSON TA, ET AL: The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 39:610-615, 1985
6. HARNETT JD, ZELDIS JB, PARFREY PS, ET AL: Hepatitis B in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation 44:369-376, 1987
7. SOPKO J, ANURAS S: Liver disease in renal transplant recipients. Am J Med 64:139-146, 1978
8. WARE AJ, LUBY JP, HOLLINGER B, ET AL: Etiology of liver disease in renal transplant recipients. Ann Intern Med 91:364-371, 1979
9. DEBURE A, DEGOS F, POL S, ET AL: Liver disease and hepatic complications in renal transplant patients. Adv Nephrol 17:375-400, 1988
10. BRAUN WE: Long-term complications of renal transplantation. (Nephrology Forum) Kidney Int 37:1363-1378, 1990
11. RAO KV, ANDERSON RW, KASISKE BL, DAHL DC: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 94:241-250, 1993
12. CHOO Q, KUO G, WEINER AJ, OVERBY LR, BRADLEY DW, HOUGHTON M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genomen. Science 244:358-362, 1989
13. KUO G, CHOO QL, ALTER HJ, ET AL: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364, 1989
14. FARCI P, ALTER HJ, WONG D, ET AL: A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325:98-104, 1991
15. ALTER HJ, PURCELL RH, SHIH JW, MELPOLDER JC, HOUGHTON M, CHOO Q-L: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500, 1989
16. ESTEBAN JI, GONZALES A, HERNANDEZ JM, ET AL: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112, 1990
17. INOUE Y, MIYAMURA T, UNAYAMA T, TAKAHASHI K: Maternal transmission of HCV. Nature 353:609, 1991
18. OKAMOTO H, SUGIYAMA Y, OKADA S, ET AL: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
19. HESS G, MASSING A, ROSSOL S, SCHÜTT H, CLEMENS R, MEYER ZUM BUSCHENFELDE K-H: Hepatitis C virus and sexual transmission. Lancet ii:987, 1989
20. KIYOSAWA K, SODEYAMA T, TANAKA E, ET AL: Hepatitis C in hospital employees with needlestick injuries. Ann Int Med 115:367-369, 1991
21. THALER MM, PAR C-K, LANDERS DVW, ET AL: Vertical transmission of hepatitis C virus. Lancet 338:17-18, 1991
22. CALABRESE G, VAGELLI G, GUASCHINO R, GONELLA M: Transmission of anti-HCV within the household of hemodialysis patients. Lancet 338:1466, 1991
23. OYMAK O, AKPOLAT T, ARIK N, ET AL: Horizontal transmission of hepatitis C virus to the spouses of patients on renal replacement therapy. Nephron 66:246-247, 1994
24. GIOVANNINI M, TAGGER A, RIBERO ML, ET AL: Maternal-infant transmission of hepatitis C virus and HIV infections: A possible interaction. Lancet 335:1166, 1990
25. PEREZ-ROMERO M, SANCHEZ-QUIJANO A, LISSEN E: Transmission of hepatitis C virus. Lancet 336:411, 1990
26. RIESTRA S, SUAREZ A, RODRIGO L: Transmission of hepatitis C virus. Lancet 336:411, 1990
27. WEINER AJ, KUO G, BRADLEY DW, ET AL: Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 335:1-3, 1990
28. OKAMOTO H, OKADA S, SUGIYAMA Y, ET AL: Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60:215-222, 1990
29. DONAHUE JG, MUÑOZ A, NESS PM, ET AL: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373, 1992
30. HOUGHTON M, WEINER A, HAN J, KUO G, CHOO QL: Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 14:381-388, 1991
31. OKAMOTO H, OKADA S, SUGIYAMA Y, ET AL: Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 72:2697-2704, 1991
32. SIMMONDS P, HOLMES EC, CHA TA, ET AL: Classification of hepatitis C virus into six major region genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 74:2391-2399, 1993
33. HIJIKATA M, KATO N, OOTSUYAMA Y, NAKAGAWA M, OHKOSHI S, SHIMOTOHNO K: Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175:220-228, 1991
34. WEINER AJ, BRAUER MJ, ROSENBLATT J, ET AL: Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848, 1991
35. NAGAYAMA R, TSUDA F, OKAMOTO H, ET AL: Genotype dependence of hepatitis C virus antibodies detectable by the first generation enzyme-linked immunosorbent assay with C100-3 protein. J Clin Invest 1529-1533, 1993
36. SIMMONDS P, ROSE KA, GRAHAM S, ET AL: Mapping of serotype-specific immunodominant epitopes in the NS-4region of hepatitis C virus (HCV)-use of type-specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3. J Clin Microbiol 31:1493-1503, 1993
37. OKAMOTO H, OKADA S, SUGIYAMA Y, ET AL: The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 60:167-177, 1990
38. CHA TA, KOLBERG J, IRVINE B, ET AL: Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol 29:2528-2534, 1991
39. HAN JH, SHYAMALA V, RICHMAN KH, ET AL: Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci USA 88:1711-1715, 1991
40. BUKH J, PURCELL RH, MILLER RH: Importance of a primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187-191, 1992
41. SIMMONDS P, ALBERTI A, ALTER HJ, ET AL: A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 19:1321-1324, 1994
42. CHA TA, BEALL E, IRVINE B, ET AL: At leat five related, but distinct hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 89:7144-7148, 1992
43. CHAN SW, MCOMISH F, HOLMES EC, ET AL: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 73:1131-1141, 1992
44. SIMMONDS P, MCOMISH F, YAP PL, ET AL: Sequence variability in the 5/non coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J Gen Virol 74:661-668, 1993
45. OKAMOTO H, KURAI F, OKADA S, ET AL: Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188:331-341, 1992
46. MORI S, KATO N, YAGYU A, ET AL: A new type of hepatitis C virus in patients in Thailand. Bichem Biophys Res Commun 183:334-342, 1992
47. ENOMOTO N, TAKADA A, NAKAO T, DATE T: There are two major types of hepatitis C virus in Japan. Biochem Biophy Res Commun 170:1021-1025, 1990
48. KOHARA KT, KOHARA M, YAMAGUCHI K, ET AL: A second group of hepatitis C viruses. Virus Genes 5:243-254, 1991
49. SIMMONDS P, ZHANG LQ, WATSON HG, ET AL: Hepatitis C quantification and sequencing in blood products, hemophiliacs, and drug users. Lancet 336:1469-1471, 1990
50. ULRICH PP, ROMEO JM, LANE PK, KELLY I, DANIAL LJ, VYAS GN: Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest 86:1609-1614, 1990
51. BUSCH MP, WILBER JC, JOHNSON PJ, TOBLER L, EVANS CS: Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 32:420-425, 1992
52. LAU JYN, DAVIS GL, ORITO E, QIAN KP, MIZOKAMI M: Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection. J Hepatol 17:253-257, 1993
53. KWOK S, HIGUCHI R: Avoiding false positives with PCR. Nature 339:237-238, 1989
54. WRIGHT TL: Hepatitis C virus infection and organ transplantation. Prog Liv Dis 11:215-230, 1993
55. URDEA MS, HORN T, FULTZ TJ, ET AL: Branched DNA amplication multimers for the sensitive, direct detection of human hepatitis viruses. Nucl Acids Res Symp Ser Oxford: Oxford University Press 24:197-200, 1991
56. LAU JYN, DAVIS GL, KNIFFEN J, ET AL: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504, 1993
57. FERAY C, SAMUEL D, THIERS V, ET AL: Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89:1361-1365, 1992
58. WIDELL A, SHEV S, MANSSON S, ET AL: Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 44:272-279, 1994
59. WEINER AJ, GEYSEN HM, CHRISTOPHERSON C, ET AL: Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 89:3468-3472, 1992
60. FARCI P, ALTER HJ, GOVINDARAJAN S, ET AL: Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140, 1992
61. KUROSAKI M, ENOMOTO N, MARUMO F, SATO C: Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293-1299, 1993
62. NAKAO T, ENOMOTO N, TAKADA N, TAKADA A, DATE T: Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 72:2105-2112, 1991
63. STUYVER L, ROSSAU R, WYSEUR A, ET AL: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102, 1993
64. AACH RD, STEVENS CE, HOLLINGER FB, ET AL: Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 325:1325-1329, 1991
65. NASOFF MS, ZEBEDEE SL, INCHAUSPÉ G, PRINCE AM: Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462-5466, 1991
66. OLIVA JA, ERCILLA G, MALLAFRE JM, BRUGUERA M, CARRIÓ J, PEREIRS BJG: Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: Implications for infection control strategies in hemodialysis units. Int J Artif Org 18:73-77, 1995
67. WARD KN, DHALIWAL W, ASHWORTH KL, CLUTTERBUCK EJ, TEO CG: Measurment of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 43:367-372, 1994
68. ALTER MJ, MARGOLIS HS, KRAWCZYNSKI K, ET AL: The natural history of community-acquired hepatitis C in the United States. The Sentinel Countries Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327:1899-1905, 1992
69. ALTER HJ: To C or not to C: These are the questions. (Review) Blood 85:1681-1695, 1995
70. LOK ASF, CHAN TM, CHAN R, CHENG IKP: HCV infection in hemodialysis (HD) patients: A comparative study using 1st and 2nd generation EIA for anti-HCV and PCR for HCV RNA. (abstract) Gastroenterology 102:845, 1992
71. DUSSOL B, CHICHEPORTICHE C, CANTALOUBE JF, ET AL: Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Am J Kid Dis 22:574-580, 1993
72. POL S, ROMEO R, ZINS B, ET AL: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 44:1097-1100, 1993
73. WILLEMS M, PEERLINCK K, MOSHAGE H, ET AL: Heaptitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemphiliacs with chronic hepatitis C: Evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 42:272-278, 1994
74. DUBOIS DB, GRETCH D, DELA ROSA C, ET AL: Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: Gender-related differences in viral load. Am J Kid Dis 24:795-801, 1994
75. SEELIG R, RENZ M, BOTTNER C, SEELIG HP: Hepatitis C virus infections in dialysis units: Prevalence of HCV-RNA and antibodies to HCV. Ann Med 26:45-52, 1994
76. SAKAMOTO N, ENOMOTO N, MARUMO F, SATO C: Prevalence of hepatitis C virus infection among long-term hemodialyis patients: Detection of hepatitis C virus RNA in plasma. J Med Virol 39:11-5, 1993
77. SHEU JC, LEE SH, WANG JT, SHIH LN, WANG TH, CHEN DS: Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 37:108-112, 1992
78. HAYASHI J, NAKASHIMA K, YOSHIMURA E, KISHIHARA Y, OHMIYA M, HIRATA M: Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan. J Infect 28:271-277, 1994
79. CHAN TM, LOK ASF, CHENG IKP, CHAN RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5-8, 1993
80. BUKH J, WANTZIN P, KROGSGAARD K, KNUDSEN F, PURCELL RH, MILLER RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 168:1343-1348, 1993
81. PEREIRA BJG, MILFORD EL, KIRKMAN RL, ET AL: Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients. N Engl J Med 327:910-915, 1992
82. OESTERREICHER C, HAMMER J, KOCH U, ET AL: HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing hemodialysis. Kidney Int 48:1967-1971, 1995
83. ZELDIS JB, DEPNER TA, KURAMOTO IK, GISH RG, HOLLAND PV: The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 112:958-960, 1990
84. MENITOVE JE, RICHARDS WA, DESTREE M: Early U.S. experience with anti-HCV kit in blood donors. Lancet 336:244-245, 1990
85. STEVENS CE, TAYLOR PE, PINDYCK J, ET AL: Epidemiology of Hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 263:49-53, 1990
86. HARDY NM, SANDRONI S, DANIELSON S, WILSON WJ: Antibody to hepatitis C virus increases with time on dialysis. Clin Nephrol 38:44-48, 1992
87. MULLER GY, ZABALETA ME, ARMINIO A, ET AL: Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 41:1055-1058, 1992
88. KÜHNL P, SEIDL S, STANGEL W, BEYER J, SIBROWSKI W, FLIK J: Antibody to hepatitis C virus in German blood donors. Lancet ii:324, 1989
89. ESTEBAN JI, ESTEBAN R, VILADOMIU L, ET AL: Hepatitis C virus antibodies among risk groups in Spain. Lancet ii:294-296, 1989
90. GROB PJ, JOLLER-JEMELKA HJ: Hepatitis virus (HCV), anti-HCV and non-A, non-B hepatitis. Schweiz Med Wochenschr 120:117-124, 1990
91. WANTZIN PS, KROGSGAARD K, DICKMEISS E: Screening of Danish blood donors for hepatitis C virus antibodies. Ugeskr Loeger 152: 2846-2848, 1990
92. SIRCHIA G, ALMINI D, BELLOBUONO A, ET AL: Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 59:26-29, 1990
93. HUBMANN R, ZAZGORNIK J, GABRIEL C, GARBEIS B, BLAUHUT B: Hepatitis C virus-does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood Nephrol Dial Transplant 10:541-542, 1995
94. TAMURA I, KOBAYASHI Y, KODA T, ET AL: Hepatitis C virus antibody in haemodialysis patients. Lancet 335:1409, 1990
95. LEE SH, CHAN CY, WANG YJ, ET AL: Seroepidemilogy of hepatitis C virus infection in Taiwan. Hepatology 13:830-833, 1991
96. COURSAGET P, LESAGE G, BOURDIL C, ET AL: Hepatitis C virus infection in diseases in tropical Africa (Senegal), International Symposium on Viral Hepatitis and Liver Disease, Houston, Texas, USA, 1990, April 4-8
97. BLACKMORE TK, MADDOCKS P, STACE NH, HATFIELD P: Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Aust NZ J Med 22:353-357, 1992
98. LUENGROJANAKUL P, VAREESANTHIP K, CHAINUVATI T, ET AL: Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol 44:287-292, 1994
99. NAKATA S, SONG P, DUC DEA: Hepatitis C, B infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Hepatol Gastroenterol 9:416-419, 1994
100. ABDEL-WAHAB MF, ZAKARIA S, KAMEL M, ET AL: High scroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hygiene 51:563-567, 1994
101. CHIARAMONTE M, RAPICETTA M, STROFTOLINI T, ET AL: The prevalence of anti-HCV in Cameroon school children, in International Symposium on Viral Hepatitis and Liver Diseases, Houston, Texas, USA, 1990, April 4-8
102. COUROUCÉ AM, BOUCHARDEAU F, CHAUVEAU P, ET AL: Hepatitis C (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 10:234-239, 1995
103. CARRERA F, SILVA JG, OLIVEIRA C, FRAZAO JM, PIRES C: Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population. Nephron 68:38-40, 1994
104. SIMON N, COUROUCÉ AM, LEMARREC N, TREPO C, DUCAMP S: A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 46:504-511, 1994
105. ALTER HJ: Chronic consequences of non-A, non-B hepatitis, in Current Perspectives in Hepatology, edited by SEEFF LB LJ, New York, Plenum Medical Books, 1989, pp 83-97
106. KIYOSAWA K, SODEYAMA T, TANAKA E, ET AL: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
107. COLOMBO M, KUO G, CHOO QL, ET AL: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2:1006-1008, 1989
108. TANAKA K, HIROHATA T, KOGA S, ET AL: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 51:2842-2847, 1991
109. SEEFF LB, BUSKELL-BALES Z, WRIGHT EC, ET AL: Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 327:1906-1911, 1992
110. VAN NESS MM, DIEHL AM: Is liver biopsy useful in evaluation of patients with chronically elevated liver enzymes? Ann Int Med 111:473-478, 1989
111. VAN DER POEL CL, REESINK HW, SCHAASBERG W, ET AL: Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 335: 558-560, 1990
112. ALTER MJ, FAVERO MS, MAYNARD JE: Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 153:1149-1151, 1986
113. JEFFERS LJ, PEREZ GO, DE MEDINA MD, ET AL: Hepatitis C infection in two urban hemodialysis units. Kidney Int 38:320-322, 1990
114. AYOOLA EA, HURAIB S, ARIF M, ET AL: Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 35:155-159, 1991
115. ROGER SD, CUNNINGHAM A, CREWE E, HARRIS DC: Hepatitis C virus infection in heamodialysis patients. Aust NZ J Med 21:22-24, 1991
116. VASILE A, ALLEGRA V, CANCIANI D, FORCHI G, MENGOZZI G: Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies. Nephron 61:318-319, 1992
117. COLOMBO P, FILIBERTI O, PORCU M, ET AL: Prevalence of hepatitis C infection in a hemodialysis unit. Nephron 61:326-327, 1992
118. AEDER MI, SHIELD CF, TEGTMEIER GE, ET AL: The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 25:1469-1471, 1993
119. ALBERTI A, MORSICA G, CHEMELLO L, ET AL: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697-698, 1992
120. WOLF PL, WILLIAM D, COPLON N, COULSON AS: Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 18:567-573, 1972
121. MONDELLI MU, SMEDILE V, PIAZZA V, ET AL: Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant 6:480-483, 1991
122. GILLI P, MORETTI M, SOFFRITTI S, ET AL: Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 13:737-741, 1990
123. MCOMISH F, CHAN SW, DOW BC, ET AL: Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13, 1993
124. YOSHIOKA K, KAKUMU S, WAKITA T, ET AL: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy. Relationship to genotypes of hepatitis C virus. Hepatology 16:293-299, 1992
125. FERAY C, GRIGOU M, SAMUEL DEA: HCV type II has a more pathogenic course after liver transplantation. (abstract) Hepatology 18:59, 1993
126. MAHANEY K, TEDESCHI V, MAERTENS G, ET AL: Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411, 1994
127. ZIBERT A, SCHREIER E, ROGGENDORF M: Antibodies in human sera to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661, 1995
128. LAI ME, MAZZOLENI AP, ARGIOLU F, ET AL: Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390, 1993
129. KAO JH, CHEN PJ, LA MY, CHEN DS: Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 105:583-587, 1993
130. OKAMOTO H, MISHIRO S, TOKITA H, TSUDA F, MIYAKAWA Y, MAYUMI M: Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 20:1131-1136, 1994
131. EVANS AA, CODY H, KUO G, ET AL: Seroepidemiology of hepatitis C virus (HCV) in selected populations. (abstract) Hepatology 10:644, 1989
132. GETZUNG T, LINDSAY K, BREZINA M, GITNICK G: Hepatitis C virus antibody in hemodialysis patients: Prevalence and risk factors. Lancet 335:A589, 1990
133. NIU MT, COLEMAN PJ, ALTER MJ: Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kid Dis 22:568-573, 1993
134. MORTIMER PP, COHEN BJ, LITTON PA, ET AL: Hepatitis C virus antibody. Lancet 2:798, 1989
135. ROGGENDORF M, DEINHARDT F, RASSHOFER R, ET AL: Antibodies to hepatitis C virus. Lancet 2:324-325, 1989
136. SCHLIPKOTER U, ROGGENDORF M, ERNST G, ET AL: Hepatitis C virus antibodies in haemodialysis patients. Lancet 335:1409, 1990
137. KALLINOWSKI B, THEILMANN L, GMELIN K, ET AL: Prevalence of antibodies to hepatitis C virus in hemodialysis patients. Nephron 59:236-238, 1991
138. ELISAF M, TSIANOS E, MAVRIDIS M, DARDAMANIS M, PAPPAS M, SIAMOPOULOS KC: Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: Association with hepatitis B serological markers. Nephrol Dial Transplant 6:476-479, 1991
139. CONWAY M, CATTERALL AP, BROWN EA, ET AL: Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 7:1226-1229, 1992
140. MALAGUTI M, CAPECE R, MARCIANO M, ET AL: Antibodies to hepatitis C virus (anti-HCV): Prevalence in the same geographical area in dialysis patients, staff members, and blood donors. Nephron 61:346, 1992
141. MONDELLI MU, CRISTINA G, PAZZA V, CERINO A, VILLA G, SALVADEO A: High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 61:350-351, 1992
142. CHAUVEAU P, COUROUCÉ AM, LEMAREC N, ET AL: Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int 46(Suppl 43):S149-S152, 1993
143. KÖKSAL I, BIBEROGLU K, BIBEROGLU S, ET AL: Hepatitis C virus antibodies among risk groups in Turkey. Infection 19:228-229, 1991
144. BAHAKIM H, BAKIR TMF, ARIF M, RAMIA S: Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang 60:162-164, 1991
145. MITWALLI A, AL-MOHAYA S, AL WAKEEL J, ET AL: Hepatitis C in chronic renal failure patients. Am J Nephrol 12:288-291, 1992
146. ALFURAYH O, SOBH M, BUALI AR, ET AL: Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant 7:327-332, 1992
147. OGUCHI H, MIYASAKA M, TOKUNAGA S, ET AL: Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 38:36-43, 1992
148. LIN DY, LIN HH, HUANG CC, LIAW YF: High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 21:288-291, 1993
149. NATOV SN, PEREIRA BJG: Hepatitis C infection in patients on dialysis. Semin Dial 7:360-368, 1994
150. MCHUTCHISON JG, PERSON JL, GOVINDARAJAN S, ET AL: Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 15:19-25, 1992
151. TOKARS J, ALTER MJ, FAVERO MS, MOYER LA, MILLER E, BLAND LA: National surveillance of hemodialysis associated diseases in the United States, 1992. ASAIO J 40:1020-1031, 1994
152. LOUREIRO A, PINTO DOS SANTOS J, SCHMID CS, ET AL: Trends in incidence of hepatitis C (HCV) infection in hemodialysis (HD) units, (abstract) J Am Soc Nephrol 6:547, 1995
153. HURAIB S, AL-RASHED R, ALDREES A, ALJEFRY M, ARIF M, AL-FALEH FA: High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 10:470-474, 1995
154. GEERLINGS W, TUFVESON G, EHRICH JHH, ET AL: Report on the management of renal failure in Europe, XXIII. Nephrol Dial Transplant 9:6-25, 1994
155. VALDERRÁBANO F, JONES EHP, MALLICK NP: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 10:1-25, 1995
156. FABRIZI F, LUNGHI G, GUARNORI I, ET AL: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 9:1611-1615, 1994
157. JADOUL M, CORNU C, VAN YPERSELE DE STRIHOU C, THE UCL COLLABORATIVE GROUP: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322-1326, 1993
158. NIU MT, ALTER MJ, KRISTENSEN C, MARGOLIS HS: Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kid Dis 19:345-352, 1992
159. PASCUAL J, TERUEL JL, MATEOS M, ET AL: Nosocomial transmission of hepatitis C virus (HCV) infection in a hemodialysis (HD) unit during two years of prospective follow-up. (abstract) J Am Soc Nephrol 3:386, 1992
160. CENDOROGLO-NETO M, DRAIBE SA, SILVA AE, ET AL: Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 10:240-246, 1995
161. VANDELLI L, MEDICI G, SAVAZZI AM, ET AL: Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis. Nephron 61:260-262, 1992
162. POL S, THIERS V, NOUSBAUM JB, ET AL: The changing relative prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108:581-583, 1995
163. KNUDSEN F, WANTZIN P, RASMUSSEN K, ET AL: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 43:1353-1356, 1993
164. DENTICO P, BUONGIORNO R, VOLPE A, ET AL: Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: Study of risk factors. Clin Nephrol 61:49-52, 1992
165. MOSCONI G, CAMPIERI C, MINIERO R, ET AL: Epidemiology of hepatitis C in a population of hemodialysis patients. Nephron 61: 298-299, 1992
166. SCOTTO G, SAVASTANO AM, FORCELLA M, ET AL: HCV infections in dialysis patients. Nephron 61:320-321, 1992
167. PONZ E, CAMPISTOL JM, BARRERA JM, ET AL: Hepatitis C virus antibodies in patients on hemodialysis and after transplantation. Transplant Proc 23:1371-1372, 1991
168. YAMAGUCHI K, NISHIMURA Y, FUKUOKA N, ET AL: Hepatitis C virus antibodies in haemodialysis patients. Lancet 335:1409-1410, 1990
169. BRUGNANO R, FRANCISCI D, QUINTALIANI G, ET AL: Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors. Nephron 61:263-265, 1992
170. CANTU P, MANGANO S, MASINI M, LIMIDO A, CROVETTI G, DEFILIPPO C: Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 61:337-338, 1992
171. MEDICI G, DEPETRI GC, MILETI M: Anti-hepatitis C virus positivity and clinical correlations in hemodialyzed patients. Nephron 61:363-364, 1992
172. SELGAS R, MARTINEZ-ZAPICO R, BAJO MA, ET AL: Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Pent Dial Int 12:28-30, 1992
173. CHAN TM, LOK ASF, CHENG IKP: Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 6:944-947, 1991
174. BESSO L, ROVERE A, PEANO G, ET AL: Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in staff members of the dialysis unit. Nephron 61:304-306, 1992
175. DUSSOL B, BERTHEZÈNE P, BRUNET P, BERLAND Y: Hepatitis C virus infection among chronic dialysis patients in the south-east of France. Nephrol Dial Transplant 10:477-478, 1995
176. MCINTYRE PG, MCCRUDEN EA, DOW BC, ET AL: Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 9:291-295, 1994
177. HUANG CC, WU MS, LIN DY, LIAW YF: The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 12:31-33, 1992
178. JONAS MM, ZILLERUELO GE, LARUE SI, ABITBOL C, STRAUSS J, LU Y: Hepatiis C infection in pediatric dialysis population. Pediatrics 89:707-709, 1992
179. BARRIL G, TRAVER JA: Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol Dial Transplant 10(Suppl 6):78-80, 1995
180. YOSHIDA CFT, TAKAHASHI C, GASPAR AMC, SCHATZMAYR HG, RUZANY F: Hepatitis C virus in chronic hemodialysis patients with non-A, non-B hepatitis. Nephron 60:150-153, 1992
181. CENDOROGLO MN, MANZANO SIR, CANZIANI MEEA: Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 19:251-255, 1995
182. BRUGUERA M, VIDAL L, SANCHEZ-TAPIAS JM, COSTA J, REVERT L, RODES J: Incidence and features of liver disease in patients on chronic hemodialysis. J Clin Gastroenterol 12:298-302, 1990
183. PINTO DOS SANTOS J, LOUREIRO A, CENDOROGLO M, PEREIRA BJG: Impact of dialysis room and reuse strategies on the incidence of HCV infection in HD units. Nephrol Dial Transplant (in press)
184. CORCORAN GD, BRINK NS, MILLAR CG, ET AL: Hepatitis C virus infection in hemodialysis patients: A clinical and virological study. J Infect Dis 28:279-285, 1994
185. SAMPIETRO M, BADALAMENTI S, SALVADORI S, ET AL: High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial trasnmission of HCV. Kidney Int 47:911-917, 1995
186. ALTER M, HADLER SC, JUDSON FN, ET AL: Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264:2231-2235, 1990
187. ROBLES NR, GOMEZ-AINSUA C, CRUZ A: Lack of transmission of hepatitis C virus in a haemodialysis unit. Nephrol Dial Transplant 7:981-982, 1992
188. PETRARULO F, MAGGI P, SACCHETTI A, PALLOTTA G, DAGOSTINO F, BASILE C: HCV infection occupational hazard at dialysis units and virus spread, among relatives of dialyzed patients. Nephron 61:302-303, 1992
189. INCANDELA L, GIOMI S, NENCIONI C, ET AL: Incidence and prevalence of anti-HCV antibodies and HBV markers in patients undergoing extracorporeal hemodialysis. (Italian) Minerva Medica 85:505-509, 1994
190. SCHLIPKOTER U, GLADZIWA U, CHOLMAKOV K, ET AL: Prevalence of hepatitis C infections in dialysis patients and their contacts using a second generation enzyme-linked immunosorbent assay. Med Microbiol Immunol 181:173-180, 1992
191. SCHLIPKÖTER U, ROGGENDORF M, CHOLMAKOW K, WEISE A, DIENHARDT: Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand J Infect Dis 22:757-758, 1990
192. MITSUI T, IWANO K, MASUKO K, ET AL: Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109-1114, 1992
193. MASUKO K, MITSUI T, IWANO K, ET AL: Factors influencing postexposure
194. BRADLEY DW: Hepatitis non-A, non-B viruses become identified as hepatitis C and E viruses. Prog Med Virol 37:101-135, 1990
195. YOSHIZAWA H, OTOH Y, IWAKIRI K, TANAKA A, TACHIBANA T: Non-A, non-B (type 1) hepatitis agent capable of inducing tubular structures in the hepatocyte cytoplasm of chimpanzees: Inactivation by formalin and heat. Gastroenterology 82:502-506, 1982
196. SHIKATA T, KARASAWA T, ABE K, ET AL: Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 136:571-576, 1977
197. PONZETTO A, HOYER BH, POPPER H, ENGLE R, PURCELL RH, GERIN JL: Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 155:122-128, 1987
198. ALTER MJ, FAVERO MS, MOYER LA, BLAND LA: National surveillance of dialysis-associated diseases in the United States, 1989. ASAIO Trans 37:97-109, 1991
199. OKUDA K, HAYASHI H, YOKOZEKI KEA: Mode of nosocomial HCV infection among chronic hemodialysis patients and its prevention. Hepatology 19:293, 1994
200. GARCIA-VALDESCASAS J, BERNAL MC, CEREZO S, GARCIA F, PEREIRA BJG: Strategies to reduce the transmission of HCV infection in hemodialysis (HD) units. (abstract) J Am Soc Nephrol 4:347, 1993
201. DA PORTO A, ADAMI A, SUSANNA F, ET AL: Hepatitis C virus in dialysis units: A multicenter study. Nephron 61:309-310, 1992
202. VAGELLI G, CALABRESE G, GUASCHINO R, GONELLA M: Effect of HCV+ patients isolation on HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 7:1070, 1992
203. YUASA T, ISHIKAWA G, MANABE S, SEKIGUCHI S, TAKEUCHI K, MIYAMURA T: The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 72:2021-2024, 1991
204. CARAMELO C, NAVAS S, ALBEROLA ML, BERMEJILLO T, REYERO A, CARRENO V: Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 66:470-473, 1994
205. LOMBARDI M, CERRAI T, DATTOLO P, ET AL: Is the dialysis membrane a safe harrier against HCV infection? Nephrol Dial Transplant 10:578-579, 1995
206. TOKARS J, ALTER MJ, FAVERO MS, MOYER LA, BLAND LE: National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 39:71-80, 1993
207. CUYPERS HTM, BRESTERS D, WINKEL IN, ET AL: Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Micro 30:3220-3224, 1992
208. NATOV SN, PEREIRA BJG: Transmission of disease by organ transplantation, in Organ and Tissue Donation for Transplantation, edited by CHAPMAN JD, WIGHT MC, London, Edward Arnold, 1996
209. PEREIRA BJG, MILFORD EL, KIRKMAN RL, LEVEY AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325:454-460, 1991
210. PEREIRA BJG, WRIGHT TL, SCHMID CH, LEVEY AS, NEW ENGLAND ORGAN BANK HEPATITIS C STUDY GROUP: A controlled study of hepatitis C transmission by organ transplantation. Lancet 345:484-487, 1995
211. ROTH D, FERNANDEZ JA, BABISCHKIN S, ET AL: Detection of hepatitis C infection among cadaver organ donors: Evidence for low transmission of disease. Ann Intern Med 117:470-475, 1992
212. HUANG CC, LAI MK, LIN MW, PAO CC, FANG JT, YAO DS: Transmission of hepatitis C virus by renal transplantation. Transplant Proc 25:1474-1475, 1993
213. VINCENTI F, LAKE J, WRIGHT T, KUO G, WEBER P, STEMPEL C: Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 55:674-675, 1993
214. GOMEZ E, AGUADO S, GAGO E, ET AL: A study of renal transplants obtained from anti-HCV positive donors. Transplant Proc 23:2654-2655, 1991
215. TRIOLO G, SQUICCIMARRO G, BALDI M, ET AL: Antohodies to hepatitis C virus in kidney transplantation. Nephron 61:276-277, 1992
216. LEFOR W, WRIGHT C, SHIRES D, KAHANA L, SPOTO E, ACKERMANN J: A preliminary outcome evaluation of the impact of HCV-AB studied in 521 cadaver vascular organ donors over a 6 years period. American Society of Transplant Physicians, 10th Annual Meeting, Chicago, 1991, May 28-29
217. TESI R, WALLER K, MORGAN C, ET AL: Transmission of hepatitis C by kidney transplantation - The risks. Transplantation 57:826-831, 1994
218. WREGHITT TG, GRAY JJ, ALLAIN J-P, ET AL: Tranmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 20:768-772, 1994
219. PRADOS MC, FRANCO A, PERDIGUERO M, MUNOZ C, DE LA SEN ML, OLIVARES J: Transmission of hepatitis C virus by kidney transplantation. Transplant Proc 24:2650-2651, 1992
220. PIRSCH JD, HEISEY D, D'ALLESANDRO AM, KNECHTLE SJ, SOLLINGER HW, BELZER FO: Transplatation of hepatitis C (HCV) kidneys: Defining the risks. American Society of Transplant Physicians, 14th Annual Meeting, Chicago, 1995, May 14-17
221. OTERO J, RODERIGUEZ M, ESCUDERO D, GOMEZ E, AGUADO S, ONA MD: Kidney transplants with positive anti-hepatitis C virus donors. Transplantation 50:1086-1087, 1990
222. PEREIRA BJG, WRIGHT TL, SCHMID CH, ET AL: Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study. Kidney Int 46:886-892, 1994
223. MENDEZ R, ASWAD S, BOGAARD T, ET AL: Donor hepatitis C antibody virus testing in renal transplantation. Transplant Proc 25:1487-1490, 1993
224. TESI RJ, WALLER MK, MORGAN CJ, ET AL: Use of low-risk HCV-positive donors for kidney transplantation. Transplant Proc 25:1472-1473, 1993
225. MENDEZ R, EL-SHAHAWY M, OBISPO E, ASWAD S, MENDEX RG: Four years follow up of hepatitis C positive kidneys into hepatitis C nerative recipients-prospective study. (abstract) J Am Soc Nephrol 6:1105, 1995
226. WIDELL A, MANSSON S, PERSSON NH, THYSELL H, HERMODSSON S, BLOHME I: Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 60:642-647, 1995
227. OLDACH D, CONSTANTINE N, SCHWEITZER E, ET AL: Clinical and virological outcomes in hepatitis C virus (HCV)-infected renal transplant recipients, American Society of Transplant Physicians, 14th Annual Meeting, Chicago, 1995, May 14-17
228. MORALES JM, CAMPISTOL JM, CASTELLANO G, ET AL: Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 47:236-240, 1995
229. MMWR: Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hepatitis C. MMWR 40:1-17, 1991
230. MIRANDA B, SANCHEZ M, SERGOVIA C, FELIPE C, MATESANZ R: Characteristics of the donors in Spain 1992. European Transplant Coordinators Organization, 8th Congress, Rodos, Greece, 1993, October 23-25
231. PEREIRA BJG, LEVEY AS: Hepatitis C infection in cadaver organ donors: Strategies to reduce transmission of infection and prevent organ waste. Pediatr Nephrol 9:S23-S28, 1995
232. UNOS: UNOS update. 10:27-31, 1994
233. PEREIRA BJG, WRIGHT TL, SCHMID CH, LEVEY AS, FOR THE NEW ENGLAND ORGAN BANK HEPATITIS C STUDY GROUP: The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60:799-805, 1995
234. STEMPEL CA, LAKE J, KUO G, VINCENTI F: Hepatitis C-Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 55:273-276, 1993
235. HUANG C-C, LIAW Y-F, LAI M-K, ET AL: The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 53:763-765, 1992
236. ROTH D, ZUCKER K, CIROCCO R, ET AL: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45:238-244, 1994
237. ROTH D: Hepatitis C virus: The nephrologist's view. Am J Kid Dis 25:3-16, 1995
238. YNARES C, JOHNSON HK, KERLIN T, CROWE D, MACDONELL R, RICHIE R: Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival-A 5- and 10-year follow-up. Transplant Proc 25:1466-1468, 1993
239. FRITSCHE C, BRANDES JC, DELANEY SR, ET AL: Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 55:1283-1287, 1993
240. ROTH D, FERNANDEZ J, DEMATTOS A, ET AL: The impact of hepatitis C virus (HCV) on the potential renal allograft recipient. (abstract) J Am Soc Nephrol 3:878, 1992
241. RUBIN RH, TOLKOFF-RUBIN NE: Infection: The new problems. Transplant Proc 21:1440-1445, 1989
242. MONDELLI MU, CRISTANA G, FILICE G, RONDANELLI EG, PIAZZA V, BARBIERI C: Anti-HCV positive patients in dialysis units? Lancet 336:244, 1990
243. ALIVANIS P, DERVENIOTIS V, DIOUDIS C, ET AL: Hepatitis C virus in antibodies in hemodialyzed and renal transplant patients: Correlation with chronic liver disease. Transplant Proc 23:2662-2663, 1991
244. MEDICI G, VANDELLI L, SAVAZZI AM, LUSVARGHI E: Hepatitis C virus (HCV) infection on maintenance hemodialysis: Biological results and clinical remarks. (abstract) J Am Soc Nephrol 1:368, 1990
245. LILIS D, HADJICONSTANTINOU V, KRAVARITIS A, DOUMAS L, LOUIZOU C: Prevalence of anti-HCV antibodies in four hemodialysis units in Athens. (abstract) Kidney Int 39:192, 1991
246. POUTEIL-NOBLE C, TARDY JC, CHOSSEGROS P, TREPO C, AYMARD M, TOURAINE JL: Hepatitis C virus infection in renal transplantation. (abstract) Kidney Int 39:1318, 1991
247. LOZANO L, NIETO J, SANCHEZ M, MARTIN JE, GRANIZO V, JARILLO MD: Evaluation of incidence of hepatitis C in in dialysis. (abstract) Kidney Int 40:379, 1991
248. CORDERO SANCHEZ M, BONDIA ROMAN A, LOPEZ OCHOA J, MARTIN SANCHEZ AM, NUNEZ GARCIA J: Anti-hepatitis C antibodies in hemodialysis. (abstract) Kidney Int 40:361, 1991
249. NATOV SN, BOUTHOT BA, RUTHAZER R, SCHMID CH, LEVEY AS, PEREIRA BJG: Effect of renal transplantation on patient survival in anti-HCV positive patients. American Society of Transplant Physicians, XV Annual Meeting, Dallas, 1996, May 26-29
250. DAVIS GL, BALART LA, SCHIFF ER, ET AL: Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 321:1501-1506, 1989
251. DI BISCEGLIE AM, MARTIN P, KASSIANIDES C, ET AL: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989
252. SHINDO M, DI BISCEGLIE AM, CHEUNG L, ET AL: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Int Med 115:700-704, 1991
253. PERRILLO RP, SCHIFF ER, DAVIS GL, ET AL: A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 323:295-301, 1990
254. KORENMAN J, BAKER B, WAGGONER J, EVERHART JE, DI BISCEGLIE AM, HOOFNAGLE JH: Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Int Med 114:629-634, 1991
255. FARCI P, MANDAS A, COIANA A, ET AL: Treatment of chronic hepatitis D with interferon alpha-2a. N Engl J Med 330:88-94, 1994
256. BLACK M, PETERS M: Alpha-interferon treatment of chronic hepatitis C: Need for accurate diagnosis in selecting patients. Ann Int Med 116:86-88, 1992
257. DI BISCEGLIE AM: Interferon therapy for chronic viral hepatitis. N Engl J Med 330:137-138, 1994
258. DI BISCEGLIE AM, HOOFNAGLE JH, KRAWCZYNSKI K: Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology 105:858-862, 1993
259. BROUWER JT, NEVENS F, KLETER GEM, ELEWAUT A, ADLER M, BRENARD REA: Treatment of chronic hepatitis C: Efficacy of interferon doseand analysis of factors predictive of response. Interim report of 350 patients treated in a Benelux multicenter study. (abstract) Hepatology 18:110, 1993
260. CHEMELLO L, ALBERTI A, ROSE K, SIMMONDS P: Hepatitis C serotype and response to interferon therapy. N Engl J Med 330:143, 1994
261. KRAMER P, TEN KATE FJW, BIJNEN AB, JEEKEL J, WEIMAR W: The pathology of interferon-induced renal allograft lesions. Transplant Proc 17:58, 1985
262. KOVARIK J, MAYER G, POHANKA E, ET AL: Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 45:402-405, 1988
263. RAO VK, ANDERSON WR: Clinical, histological outcome following interferon treatment of chronic viral hepatitis in uremic patients, before, after renal transplantation. ASTP Abstract 1995, p 99
264. POL S, THIERS V, CARNOT F, ET AL: Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 47:1412-1418, 1995
265. ROSTAING L, IZOPET J, BARON E, ET AL: Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients. Nephrol Dial Transplant 10:93-96, 1995
266. CASANOVAS TT, BALIELLAS C, SESE E, ET AL: Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant. Transplant Proc 27:2229-2230, 1995
267. KOENIG P, VOGEL W, UMLAUFT F, WEYRER K, PROMMEGGER R, LHOTTA K: Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney International 45:1507-1509, 1994
268. DUARTE R, HURAIB S, SAID R, ET AL: Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis. Am J Kid Dis 25:40-45, 1995
269. HARIHARA Y, KUROOKA Y, YANAGISAWA T, KUZUHARA K, OTSUBO O, KUMADA H: Interferon therapy in renal allograft recipients with chronic hepatitis C. Transplant Proc 26:2075, 1994
270. RAPTOPOULOU-GIGI M, SPAIA S, GARIFALLOS A, ET AL: Interferon-alpha2b treatment of chronic hepatitis C in haemodialysis patients. Nephrol Dial Transplant 10:1834-1837, 1995
271. OZGUR O, BOYACIOGLU S, TELATAR H, HABERAL M: Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 10:2104-2106, 1995
272. CHAN TM, LOK ASF, CHENG IKP, NG IOL: Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon. Transplantation 56:1095-1098, 1993
273. POYNARD T, BEDROSSA P, CHEVALLIER M, ET AL: A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995